首页> 外国专利> pharmaceutically acceptable salt of an amphiphilic photosensitizing agent, pharmaceutical composition, product, kit, use of a pharmaceutically acceptable salt of an amphiphilic photosensitizing agent, and method of introducing a drug molecule into the cytosol of a cell in a patient.

pharmaceutically acceptable salt of an amphiphilic photosensitizing agent, pharmaceutical composition, product, kit, use of a pharmaceutically acceptable salt of an amphiphilic photosensitizing agent, and method of introducing a drug molecule into the cytosol of a cell in a patient.

机译:两亲光敏剂的药学上可接受的盐,药物组合物,产品,试剂盒,两亲光敏剂的药学上可接受的盐的用途以及将药物分子引入患者细胞胞质中的方法。

摘要

The invention relates to pharmaceutically acceptable salts of amphiphilic photosensitizing agents which have a water solubility of at least 0.5 mg/ml and to their use in methods of photochemical internalization. Such salts may be formed from a pharmaceutically acceptable base, for example an organic amine such as an amino alcohol, or from a pharmaceutically acceptable acid, for example a sulphonic acid or a sulphonic acid derivative. Due to their increased water solubility, such salts are particularly suitable for use in the preparation of parenteral pharmaceutical preparations, e.g. for use as solutions for injection or infusion.
机译:本发明涉及水溶性至少为0.5mg / ml的两亲性光敏剂的药学上可接受的盐及其在光化学内在化方法中的用途。这样的盐可以由药学上可接受的碱例如有机胺如氨基醇形成,或者由药学上可接受的酸例如磺酸或磺酸衍生物形成。由于它们增加的水溶性,所以这些盐特别适合用于肠胃外药物制剂的制备,例如肠胃外药物制剂。用作注射或输注溶液。

著录项

  • 公开/公告号BR112012003283A8

    专利类型

  • 公开/公告日2016-05-17

    原文格式PDF

  • 申请/专利权人 PCI BIOTECH AS;

    申请/专利号BR20121103283

  • 发明设计人 ANDERS HOGSET;JO KLAVENESS;

    申请日2010-08-16

  • 分类号A61K9;A61K41;A61K48;A61P35;A61P43;C12N15/87;

  • 国家 BR

  • 入库时间 2022-08-21 14:27:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号